Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: A Children's Oncology Group report

S. Goldman, Lynette M Smith, J. R. Anderson, S. Perkins, L. Harrison, M. B. Geyer, T. G. Gross, H. Weinstein, S. Bergeron, B. Shiramizu, W. Sanger, M. Barth, J. Zhi, M. S. Cairo

Research output: Contribution to journalLetter

74 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1174-1177
Number of pages4
JournalLeukemia
Volume27
Issue number5
DOIs
StatePublished - May 1 2013

Fingerprint

Murine-Derived Monoclonal Antibodies
Antineoplastic Combined Chemotherapy Protocols
Neoplasm Staging
Vincristine
B-Cell Lymphoma
Preschool Children
Prednisone
Methotrexate
Non-Hodgkin's Lymphoma
Doxorubicin
Cyclophosphamide
Drug Therapy
Rituximab

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma : A Children's Oncology Group report. / Goldman, S.; Smith, Lynette M; Anderson, J. R.; Perkins, S.; Harrison, L.; Geyer, M. B.; Gross, T. G.; Weinstein, H.; Bergeron, S.; Shiramizu, B.; Sanger, W.; Barth, M.; Zhi, J.; Cairo, M. S.

In: Leukemia, Vol. 27, No. 5, 01.05.2013, p. 1174-1177.

Research output: Contribution to journalLetter

Goldman, S, Smith, LM, Anderson, JR, Perkins, S, Harrison, L, Geyer, MB, Gross, TG, Weinstein, H, Bergeron, S, Shiramizu, B, Sanger, W, Barth, M, Zhi, J & Cairo, MS 2013, 'Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: A Children's Oncology Group report', Leukemia, vol. 27, no. 5, pp. 1174-1177. https://doi.org/10.1038/leu.2012.255
Goldman, S. ; Smith, Lynette M ; Anderson, J. R. ; Perkins, S. ; Harrison, L. ; Geyer, M. B. ; Gross, T. G. ; Weinstein, H. ; Bergeron, S. ; Shiramizu, B. ; Sanger, W. ; Barth, M. ; Zhi, J. ; Cairo, M. S. / Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma : A Children's Oncology Group report. In: Leukemia. 2013 ; Vol. 27, No. 5. pp. 1174-1177.
@article{5f2710ceb23c4719aa94f72480d6824e,
title = "Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: A Children's Oncology Group report",
author = "S. Goldman and Smith, {Lynette M} and Anderson, {J. R.} and S. Perkins and L. Harrison and Geyer, {M. B.} and Gross, {T. G.} and H. Weinstein and S. Bergeron and B. Shiramizu and W. Sanger and M. Barth and J. Zhi and Cairo, {M. S.}",
year = "2013",
month = "5",
day = "1",
doi = "10.1038/leu.2012.255",
language = "English (US)",
volume = "27",
pages = "1174--1177",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma

T2 - A Children's Oncology Group report

AU - Goldman, S.

AU - Smith, Lynette M

AU - Anderson, J. R.

AU - Perkins, S.

AU - Harrison, L.

AU - Geyer, M. B.

AU - Gross, T. G.

AU - Weinstein, H.

AU - Bergeron, S.

AU - Shiramizu, B.

AU - Sanger, W.

AU - Barth, M.

AU - Zhi, J.

AU - Cairo, M. S.

PY - 2013/5/1

Y1 - 2013/5/1

UR - http://www.scopus.com/inward/record.url?scp=84877619828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877619828&partnerID=8YFLogxK

U2 - 10.1038/leu.2012.255

DO - 10.1038/leu.2012.255

M3 - Letter

C2 - 22940833

AN - SCOPUS:84877619828

VL - 27

SP - 1174

EP - 1177

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 5

ER -